New options for spontaneous bacterial prophylaxis: costly or cost effective?
Levy
M J
MJ
Division of Gastroenterology, University of South Alabama, Mobile, USA.
DiPalma
J A
JA
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000517:prevention & control*; D002939:Ciprofloxacin / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D010538:Peritonitis / Q000382:microbiology / Q000517:prevention & control*; D011446:Prospective Studies
D000890:Anti-Infective Agents; D002939:Ciprofloxacin